Global Nanotechnology in Drug Delivery Industry

 Representing the developed world, the United States will maintain an 18.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.9 Billion to the region’s size and clout in the next 5 to 6 years. Over US$3.4 Billion worth of projected demand in the region will come from the Rest of Europe markets. In Japan, Nanocrystals will reach a market size of US$3.5 Billion by the close of the analysis period. As the world’s second-largest economy and the new game-changer in global markets, China exhibits the potential to grow at 25.6% over the next couple of years and add approximately US$26 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring the quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape the growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America, and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

·         AbbVie Inc.

• Aquanova AG
• BlueWillow Biologics
• Camurus AB
• Celgene, Inc.
• Ceramisphere Health Pty Limited
• Cristal Therapeutics
• CYTIMMUNE SCIENCES, Inc.
• EnColl Corporation
• EyePoint Pharmaceuticals
• Lena Nanoceutics Ltd.
• NanOlogy LLC
• NanoCarrier Co., Ltd.

 GLOBAL MARKET PERSPECTIVE

Table 1: Nanotechnology in Drug Delivery Global Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 2: Nanotechnology in Drug Delivery Market Share Shift
across Key Geographies Worldwide: 2019 VS 2025
Table 3: Nanocrystals (Technology) World Market by
Region/Country in US$ Million: 2018 to 2025